{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:34:54Z","timestamp":1774524894902,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014825","name":"Biotechnology Industry Research Assistance Council","doi-asserted-by":"publisher","award":["Christian Medical College, Vellore - BIRAC\/BT\/NBM0205\/05\/19BCX1XD"],"award-info":[{"award-number":["Christian Medical College, Vellore - BIRAC\/BT\/NBM0205\/05\/19BCX1XD"]}],"id":[{"id":"10.13039\/501100014825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014825","name":"Biotechnology Industry Research Assistance Council","doi-asserted-by":"publisher","award":["ICMR-National Institute of Epidemiology - BIRAC\/BT\/NBM0206\/05\/19BCX1XD"],"award-info":[{"award-number":["ICMR-National Institute of Epidemiology - BIRAC\/BT\/NBM0206\/05\/19BCX1XD"]}],"id":[{"id":"10.13039\/501100014825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014825","name":"Biotechnology Industry Research Assistance Council","doi-asserted-by":"publisher","award":["K.E.M. Hospital Research Center, Pune - BIRAC\/GCI\/2020\/COVID-19\/Serosurveillance\/KEMVadu"],"award-info":[{"award-number":["K.E.M. Hospital Research Center, Pune - BIRAC\/GCI\/2020\/COVID-19\/Serosurveillance\/KEMVadu"]}],"id":[{"id":"10.13039\/501100014825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014825","name":"Biotechnology Industry Research Assistance Council","doi-asserted-by":"publisher","award":["Society For Health Allied Research &amp; Education India (SHARE India) - BIRAC\/BT\/NBM0203\/05\/19\/BCX1XD"],"award-info":[{"award-number":["Society For Health Allied Research &amp; Education India (SHARE India) - BIRAC\/BT\/NBM0203\/05\/19\/BCX1XD"]}],"id":[{"id":"10.13039\/501100014825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014825","name":"Biotechnology Industry Research Assistance Council","doi-asserted-by":"publisher","award":["The INCLEN Trust International - BIRAC\/BT\/NBM0253\/05\/19BCX1XD"],"award-info":[{"award-number":["The INCLEN Trust International - BIRAC\/BT\/NBM0253\/05\/19BCX1XD"]}],"id":[{"id":"10.13039\/501100014825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Large-scale sero-prevalence studies with representation from all age groups are required to estimate the true burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in the community. Serial serological surveys in fixed cohorts enable study of dynamics of viral transmission and correlates of immune response over time in the context of gradual introduction of COVID-19 vaccines and repeated upsurge of cases during the pandemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This longitudinal study will involve follow-up of a cohort of 25,000 individuals (5,000 per site) aged 2 years and above recruited from five existing demographic surveillance sites in India. The cohort will be tested for the presence of IgG antibodies against S1\/S2 spike protein subunits of SARS-CoV-2 in four rounds; once at baseline and subsequently, at intervals of 4 months for a year between January 2021 and January 2022. Neutralization assays will be carried out in a subset of seropositive samples in each round to quantify the antibody response and to estimate the durability of antibody response. Serial serological surveys will be complemented by fortnightly phone based syndromic surveillance to assess the burden of symptomatic acute febrile illness\/ influenza like illness in the same cohort. A bio-repository will also be established to store the serum samples collected in all rounds of serological surveys.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The population based sero-epidemiological studies will help to determine the burden of COVID-19 at the community level in urban and rural Indian populations and guide in monitoring the trends in the transmission of SARS-CoV-2 infection. Risk factors for infection will be identified to inform future control strategies. The serial serological surveys in the same set of participants will help determine the viral transmission dynamics and durability of neutralizing immune response in participants with or without symptomatic COVID infection.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.810353","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:13:46Z","timestamp":1648516426000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Sero-Surveillance to Monitor the Trend of SARS-CoV-2 Infection Transmission in India: Study Protocol for a Multi Site, Community Based Longitudinal Cohort Study"],"prefix":"10.3389","volume":"10","author":[{"given":"Divya","family":"Nair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reshma","family":"Raju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudipto","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra","family":"Dandge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish Kumar","family":"Chethrapilly Purushothaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuvaraj","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boopathi","family":"Kangusamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra Kumar","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winsley","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Juvekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guru Rajesh","family":"Jammy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Mehendale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabu","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha Taneja","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"B1","unstructured":""},{"key":"B2","unstructured":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"100717","DOI":"10.1016\/j.eclinm.2020.100717","article-title":"Descriptive epidemiology of SARS-CoV-2 infection in Karnataka state, South India: Transmission dynamics of symptomatic vs. asymptomatic infections","volume":"32","author":"Kumar","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"m1375","DOI":"10.1136\/bmj.m1375","article-title":"Covid-19: four fifths of cases are asymptomatic, China figures indicate","volume":"369","author":"Day","year":"2020","journal-title":"BMJ."},{"key":"B5","unstructured":"A Coordinated Global Research Roadmap"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e64206","DOI":"10.7554\/eLife.64206.sa2","article-title":"Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys","volume":"10","author":"Larremore","year":"2021","journal-title":"eLife."},{"key":"B7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jama.2020.14017","article-title":"Serosurveillance and the COVID-19 epidemic in the US: undetected, uncertain, and out of control","volume":"324","author":"Brown","year":"2020","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ijid.2020.10.011","article-title":"Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: an up-to-date review","volume":"101","author":"Lai","year":"2020","journal-title":"Int J Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(20)30544-1","article-title":"SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey","volume":"9","author":"Murhekar","year":"2021","journal-title":"Lancet Glob Health."},{"key":"B10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/ijmr.IJMR_3290_20","article-title":"Prevalence of SARS-CoV-2 infection in India: findings from the national serosurvey, May-June 2020","volume":"152","author":"Murhekar","year":"2020","journal-title":"Indian J Med Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2139\/ssrn.3689618","article-title":"Seroprevalence of COVID-19 amongst health care workers in a tertiary care hospital of a metropolitan city from India","volume":"68","author":"Goenka","year":"2020","journal-title":"J Assoc Phys India."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e66537","DOI":"10.7554\/eLife.66537.sa2","article-title":"Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2","volume":"10","author":"Naushin","year":"2021","journal-title":"eLife."},{"key":"B13","unstructured":"Coronavirus Coronavirus | Two-Thirds of Indians Have Antibodies Shows ICMR Survey2021"},{"key":"B14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3389\/fimmu.2020.610688","article-title":"Humoral responses and serological assays in SARS-CoV-2 infections","volume":"11","author":"Galipeau","year":"2020","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2000421","DOI":"10.2807\/1560-7917.ES.2020.25.16.2000421","article-title":"Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020","volume":"25","author":"Perera","year":"2020","journal-title":"Eurosurveillance."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e000722","DOI":"10.1136\/bmjpo-2020-000722","article-title":"Role of children in the transmission of the COVID-19 pandemic: a rapid scoping review","volume":"4","author":"Rajmil","year":"2020","journal-title":"BMJ Paediatr Open."},{"key":"B17","doi-asserted-by":"publisher","first-page":"100433","DOI":"10.1016\/j.eclinm.2020.100433","article-title":"COVID-19 in 7780 pediatric patients: A systematic review","volume":"24","author":"Hoang","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1056\/NEJMp2002125","article-title":"Defining the epidemiology of covid-19 \u2014 studies needed","volume":"382","author":"Lipsitch","year":"2020","journal-title":"N Engl J Med."},{"key":"B19","unstructured":"Clinical Trial Network"},{"key":"B20","first-page":"41","article-title":"Health metrics improve childhood zimmunization coverage in a rural population of Andhra Pradesh","volume":"53","author":"Tatineni","year":"2009","journal-title":"Indian J Public Health."},{"key":"B21","unstructured":"OpenEpi Menu"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e01224","DOI":"10.1128\/JCM.01224-20","article-title":"Clinical and analytical performance of an automated serological test that identifies S1\/S2-neutralizing IgG in COVID-19 patients semiquantitatively","volume":"58","author":"Bonelli","year":"2020","journal-title":"J Clin Microbiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4269\/ajtmh.21-0014","article-title":"Early and high SARS-CoV-2 neutralizing antibodies are associated with severity in COVID-19 patients from India","volume":"105","author":"Shrivastava","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/vim.2020.0321","article-title":"Antibody (IgA, IgG, and IgG Subtype) responses to SARS-CoV-2 in severe and nonsevere COVID-19 patients","volume":"34","author":"Patil","year":"2021","journal-title":"Viral Immunol."},{"key":"B25","unstructured":""},{"key":"B26","doi-asserted-by":"publisher","first-page":"577018","DOI":"10.3389\/fpubh.2020.577018","article-title":"Stigma and discrimination during COVID-19 pandemic","volume":"8","author":"Bhanot","year":"2021","journal-title":"Front Public Health."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2444","DOI":"10.1093\/cid\/ciaa1207","article-title":"Potential antigenic cross-reactivity between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and dengue viruses","volume":"73","author":"Lustig","year":"2021","journal-title":"Clin Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"001369","DOI":"10.1099\/jmm.0.001369","article-title":"Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests","volume":"70","author":"Nath","year":"2021","journal-title":"J Med Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"115313","DOI":"10.1016\/j.diagmicrobio.2021.115313","article-title":"Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays","volume":"100","author":"Tanis","year":"2021","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B30","unstructured":"2021"},{"key":"B31","unstructured":"2017"},{"key":"B32","unstructured":"2020"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.810353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:13:56Z","timestamp":1648516436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.810353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":32,"alternative-id":["10.3389\/fpubh.2022.810353"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.810353","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"article-number":"810353"}}